David Booth

Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ.

Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL.

Aerogen Ltd. develops and manufactures aerosol products. It offers Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-X controller and USB controller. The company was founded by John S. Power in 1997 and is headquartered in Galway, Ireland.

Part of Stryker Corp., Surpass Medical Ltd. is an Israeli company that provides medical devices. The company is based in Tel Aviv, Israel. Surpass Medical was acquired by Stryker Corp. on November 01, 2012 for $134.99 million.

Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands.

BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Forest Gate Energy Inc. operates as an exploration and mine development resource company. It focuses on oil and gas production properties. The company was founded by Michael C. Judson on June 25, 1999 and is headquartered in Montreal, Canada.

Eloda Corp. is an independent third party providing a suite of innovative near real-time monitoring and measuring tools for the advertising industry in the North American market. Eloda offers to Advertisers Eloda Protocol™, which is a suite of user-friendly web based applications managing TV media campaigns in-flight. The company was founded in 2000 and is headquartered in Montréal, Canada.

Iantrek Inc provides biotechnology services. The company is headquartered in White Plains, NY.

CurvaFix, Inc. operates as an emerging medical device company. It develops novel solution for an unmet need in orthopedic trauma. The company is headquartered in Bellevue, WA.

Cagent Vascular LLC engages in manufacturing medical instruments. The company was founded by Carol Burns, Robert Giasolli and Peter Schneider and is headquartered in Wayne, PA.

Neuros Medical, Inc. develops neurostimulation therapies. It offers Altius System that consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices. The company was founded by Jon J. Snyder, Kevin L. Kilgore, and Niloy Bhadra in 2008 and is headquartered in Willoughby Hills, OH.

HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Part of Medtronic Plc, Medtronic Canada ULC is a leading Canadian healthcare technology company that aims to alleviate pain, restore health, and extend life by providing innovative technologies and therapies. With a team of over 90,000 passionate people, they address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Medtronic Canada ULC has been proudly serving Canadian healthcare for over 50 years and is headquartered in Brampton, Ontario, with regional offices in Vancouver. The company's mission is to transform the lives of two people every second, every hour, every day, by engineering the extraordinary.

ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

TEC Canada is a leadership development program that offers peer advisory boards and one-to-one coaching to executives. The private company is based in Canada. With 60 years of business expertise, the program aims to provide comprehensive training to its members.

Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany.

Occlutech International AB develops and supplies occluders, accessories, and special cardiac implant products. Its products include Occlutech muscular ventricular septal defect, programmable logic device, sizing balloon, Figulla Flex II, sizing Occlutech autism spectrum disorder, and PDA occluder. The company is headquartered in Helsingborg, Sweden.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.